WRS Therapeutics Company
WRS Therapeutics is targeting the multi-billion dollar injectables market with large molecule drugs delivered orally.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
2015
Estimated Revenue:
Less than $1M
Register and Claim Ownership